[50] showed ADAMTSL4 to be directly linked to poor prognosis in patients with Glioblastoma Multiforme and the expression of ADAMTSL4 to be correlated with immune responses such as infiltration of the tumour by immune cells. This evidence concerns the gene ADAMTSL4 and glioblastoma.